Coronavirus

India has granted emergency approval to the world's first DNA vaccine for COVID-19.

Pfizer’s shot has become the first FDA-approved COVID-19 vaccine, making the transition from emergency use authorization on August 23.

A grassroots approach to vaccine education is happening in the heart of the civil rights movement in Alabama. Does this church hold the key to overcoming medical mistrust?

An experimental drug that stopped the coronavirus from entering cells in heart organoids may be able to prevent heart damage from COVID-19.

Pharma giant Pfizer has already developed and manufactured ingredients for a COVID-19 vaccine targeting the highly contagious Delta variant.

Can AI create vaccines that work against mutations that haven't happened yet, groups of viruses, and virus too tricky to currently stop?

An equitable door-to-door vaccination campaign might be just what it takes to help the U.S.’s most vulnerable communities fight COVID-19.

A new CRISPR treatment that halted coronavirus transmission in human cells could be the easy-to-distribute COVID-19 drug the world needs.

Using a “chimeric” spike protein, researchers have immunized mice against multiple types of coronaviruses with one shot.

Any revised version of the Moderna COVID-19 vaccine will likely include a smaller dose, reducing side effects and increasing the supply of shots.